A dark money anti-pharma bus —A rare disease treatment approval for Zevra —An FTC lawsuit against pharmacy benefit managers ...
It said the drug did not 'achieve statistical significance' in terms of the survival rates of those suffering from breast ...
It is a fictional representation created for illustrative purposes only. AstraZeneca's experimental precision drug, developed ...